Clinical Trial Update: Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis [Phase 3]

View source ↗

Summary

Phase III clinical study of NPB-01 in autoimmune encephalitis is ongoing with no status available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• NPB-01

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Autoimmune Encephalitis | Phase 3 | Status: UNKNOWN